Investigational Site Number 840452

Washington D.C., District of Columbia 20037

0 studies enrolling now · 1 studies all time

What they study most

Hypercholesterolemia

Studies at this site

• Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy — Completed